A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

NCT02610283 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: QPI-1002
DRUG: Placebo

Sponsor

Quark Pharmaceuticals